Cognitive Remediation Therapy for Schizophrenia
(RC2S Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test a cognitive therapy program called RC2S+ (Remédiation Cognitive de la Cognition Sociale en Schizophrénie) to determine its effectiveness and ease of use for individuals with schizophrenia and related disorders. Participants will engage in 24 online sessions to enhance social skills, such as recognizing emotions and understanding others' perspectives. The trial seeks individuals diagnosed with schizophrenia or a similar disorder who experience difficulties with social interactions and have internet access. Participants should not have other neurological issues or be currently hospitalized. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could improve social skills therapy for schizophrenia.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the RC2S+ program is safe for people with schizophrenia?
Research has shown that the RC2S+ program, a therapy designed to enhance thinking skills in people with schizophrenia, is generally well-tolerated. In past studies, similar programs improved social skills without major side effects.
Although detailed information on negative reactions to RC2S+ is limited, therapies of this kind are usually safe because they involve mental exercises rather than medications. This typically means they don't cause the physical side effects that drugs might.
For those considering joining a trial for RC2S+, research so far suggests it is a safe method to address social challenges related to schizophrenia.12345Why are researchers excited about this trial?
RC2S+ is unique because it focuses specifically on cognitive remediation for social cognition in schizophrenia. Unlike traditional antipsychotic medications that primarily target symptoms like hallucinations and delusions, RC2S+ aims to improve social interaction and cognitive function through 24 biweekly sessions. Researchers are excited about this approach as it addresses a crucial aspect of daily functioning in schizophrenia, potentially enhancing the quality of life and social integration for patients.
What evidence suggests that the RC2S+ program is effective for schizophrenia?
Research has shown that programs like RC2S+, which participants in this trial will receive, can help people with schizophrenia. These programs focus on improving social cognition, which involves understanding and interacting with others. Studies have found that these treatments can enhance cognitive abilities, such as memory and attention. This improvement is important because better cognitive skills can enhance daily life and job performance. Early findings suggest that participants in these programs often notice positive changes in their social interactions and thinking skills.678910
Are You a Good Fit for This Trial?
This trial is for adults with schizophrenia or related psychotic disorders who are stable and treated at the Douglas Mental Health University Hospital. They must have trouble with social cognition, access to digital technology and a private space, and be able to nominate an emergency contact. People can't join if they're hospitalized, don't speak French or English, have cognitive issues due to organic causes like brain trauma, or have mental retardation or autism.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 24 biweekly individual sessions of RC2S+ with a therapist
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Remédiation Cognitive de la Cognition Sociale en Schizophrénie (RC2S+)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Douglas Mental Health University Institute
Lead Sponsor
McGill University
Lead Sponsor